-
AUPH Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Aurinia Pharmaceuticals (AUPH)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 37.14 mm | 37.14 mm | 37.14 mm | 37.14 mm | 37.14 mm | 37.14 mm |
Cash burn (monthly) | (no burn) | 771.25 k | (no burn) | 2.47 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | 2.16 mm | n/a | 6.93 mm | n/a | n/a |
Cash remaining | n/a | 34.98 mm | n/a | 30.21 mm | n/a | n/a |
Runway (months of cash) | n/a | 45.4 | n/a | 12.2 | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 178 |
Opened positions | 30 |
Closed positions | 22 |
Increased positions | 51 |
Reduced positions | 44 |
13F shares | Current |
---|---|
Total value | 407.71 bn |
Total shares | 63.74 mm |
Total puts | 1.51 mm |
Total calls | 1.14 mm |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 9.07 mm | $66.45 bn |
Armistice Capital | 8.20 mm | $60.11 bn |
Tang Capital Management | 7.23 mm | $52.99 bn |
ILJIN SNT | 6.40 mm | $0.00 |
NEA Management | 3.97 mm | $29.10 bn |
STT State Street | 2.95 mm | $21.59 bn |
GS The Goldman Sachs Group, Inc. | 2.41 mm | $17.65 bn |
Geode Capital Management | 1.77 mm | $12.95 bn |
Vanguard | 1.62 mm | $11.86 bn |
MS Morgan Stanley | 1.47 mm | $10.78 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Dec 24 | Tang Kevin C | Common Shares | Buy | Acquire P | Yes | No | 9.09 | 500,000 | 4.55 mm | 8,429,500 |
6 Dec 24 | Tang Kevin C | Common Shares | Buy | Acquire P | Yes | No | 9.01 | 400,000 | 3.60 mm | 7,929,500 |
5 Dec 24 | Tang Kevin C | Common Shares | Buy | Acquire P | Yes | No | 8.91 | 300,000 | 2.67 mm | 7,529,500 |
21 Nov 24 | David R.W. Jayne | Common Shares | Grant | Acquire A | No | No | 0 | 12,135 | 0.00 | 56,499 |
21 Nov 24 | David R.W. Jayne | Director Stock Option Common Shares | Grant | Acquire A | No | No | 8.24 | 18,641 | 153.60 k | 18,641 |
21 Nov 24 | Bailey Jeffrey Allen | Common Shares | Grant | Acquire A | No | No | 0 | 12,135 | 0.00 | 25,491 |
21 Nov 24 | Bailey Jeffrey Allen | Director Stock Option Common Shares | Grant | Acquire A | No | No | 8.24 | 18,641 | 153.60 k | 18,641 |
21 Nov 24 | Johnson Craig A | Common Shares | Grant | Acquire A | No | No | 0 | 20,631 | 0.00 | 20,631 |
21 Nov 24 | Johnson Craig A | Director Stock Option Common Shares | Grant | Acquire A | No | No | 8.24 | 31,688 | 261.11 k | 31,688 |
21 Nov 24 | Jill Leversage | Common Shares | Grant | Acquire A | No | No | 0 | 12,135 | 0.00 | 25,053 |